Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA4 | P22748 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALPG | P10696 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triphenylphosphine Oxide SCHEMBL513223 | 0.97 | CA2 (0.58) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL3949 | 0.97 | CA2 (0.58) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL3753871 | 0.93 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL8431251 | 0.93 | CA2 (0.63) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL11214761 | 0.93 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL9425396 | 0.93 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| SCHEMBL5439069 | 0.93 | LMNA (0.60) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL7991003 | 0.93 | CA2 (0.55) | CA2CA4CA5ALMNACFTR | |
| SCHEMBL132983 | 0.93 | LMNA (0.60) | CA2CA4CA5ALMNACFTR | |
| Triphenylphosphine Oxide SCHEMBL7551485 | 0.93 | CA2 (0.55) | CA2CA4CA5ALMNACFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117088852-B | Preparation and palladium removal method of crizotinib intermediate | 山东省科学院菏泽分院 | 2024-04-16 | — | — | CN | claimed |
| CN-117088852-A | Preparation and palladium removal method of crizotinib intermediate | 山东省科学院菏泽分院 | 2023-11-21 | — | — | CN | claimed |
| CN-106221280-A | Novel organic dye sensitizer containing BODIPY conjugated units and preparation method thereof | 东莞理工学院 | 2016-12-14 | — | — | CN | claimed |
| CN-103524486-B | The beta-lactam compound that N-quinolyl replaces and pharmaceutical composition and synthetic method and application | KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES (CN) | 2016-03-02 | — | — | CN | claimed |
| CN-103524486-A | N-quinolyl substituted beta-lactam compound, as well as pharmaceutical composition, synthetic method and application of compound | KUNMING INST BOTANY CN ACAD | 2014-01-22 | — | — | CN | claimed |
| CN-1314691-C | Faropenem sodium preparation method | LUNAN PHARM GROUP CORP (CN) | 2007-05-09 | — | — | CN | claimed |
| CN-1255379-C | E-alpha-chloro alkyllene-beta-lactan compound synthetic method and its use | SHANGHAI INST ORGANIC CHEM (CN) | 2006-05-10 | — | — | CN | claimed |
| CN-1733772-A | Faropenem sodium preparation method | LUNAN PHARM GROUP CORP (CN) | 2006-02-15 | — | — | CN | claimed |
| CN-1616423-A | E-alpha-chloro alkyllene-beta-lactan compound synthetic method and its use | SHANGHAI INST ORGANIC CHEM (CN) | 2005-05-18 | — | — | CN | claimed |
| CN-1523022-A | Z-alpha-halogenated alkylidene-beta-lactone compound, synthesis method and use thereof | 中国科学院上海有机化学研究所 | 2004-08-25 | — | — | CN | claimed |
| CN-117088852-B | Preparation and palladium removal method of crizotinib intermediate | 山东省科学院菏泽分院 | 2024-04-16 | — | — | CN | disclosed |
| CN-117088852-B | Preparation and palladium removal method of crizotinib intermediate | 山东省科学院菏泽分院 | 2024-04-16 | — | — | CN | disclosed |
| CN-117483004-A | Palladium-containing composition and method for producing hydrogen peroxide | 三菱瓦斯化学株式会社 | 2024-02-02 | — | — | CN | disclosed |
| US-11883809-B2 | Palladium-containing composition and hydrogen peroxide production method | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-01-30 | — | — | US | disclosed |
| CN-117088852-A | Preparation and palladium removal method of crizotinib intermediate | 山东省科学院菏泽分院 | 2023-11-21 | — | — | CN | disclosed |
| CN-1216556-A | Polymers with spiro atoms and their use as electroluminescent materials | HOECHST AG (DE) | 1999-05-12 | — | — | CN | disclosed |
| CN-1216539-A | Heterocyclic azahexane derivatives with antiviral activity | NOVARTIS AG (CH) | 1999-05-12 | — | — | CN | disclosed |
| CN-1197452-A | Azetidinone derivatives for treatment of atherosclerosis | SMITHKLINE BEECHAM PLC (GB) | 1998-10-28 | — | — | CN | disclosed |
| CN-1023399-C | 8-Substituted-2-aminotetralines | ASTRA AB (SE) | 1994-01-05 | — | — | CN | disclosed |
| CN-1047494-A | 2-amino-1,2,3,4-tetralin compounds that new 8-replaces | ASTRA AB (SE) | 1990-12-05 | — | — | CN | disclosed |